Format

Send to

Choose Destination
J Surg Oncol. 2015 Jan;111(1):81-90. doi: 10.1002/jso.23732. Epub 2014 Aug 5.

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

Author information

1
University of Southern California Department of Surgery, Division of Breast and Soft Tissue Surgery, Norris Comprehensive Cancer Center, Los Angeles, California.

Abstract

Precision medicine involves understanding the molecular drivers unique to an individual patient's cancer so that specific factors may be targeted with the goal of improved patient outcomes. The purpose of this article is to review standard of care and research grade (non-standard of care) biomarkers in breast cancer that may be useful for diagnosis, prognosis and targeted therapy.

KEYWORDS:

biomarker; breast cancer; molecular marker; personalized medicine; precision medicine

PMID:
25091830
DOI:
10.1002/jso.23732
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center